Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 |
filingDate |
1994-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4f46673d9e25cf2ef7bc22e48e025d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57ee6238e1280948c9c3f99daf60ecf |
publicationDate |
1995-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2168043-A1 |
titleOfInvention |
Method to inhibit restenosis |
abstract |
A pharmaceutical composition to inhibit the development of intimal hyperplasia following vascular (angioplasty) is disclosed. The pharmaceutical composition contains green porphyrin and is administered to the subject concurrent with and following the angioplasty. No purposeful irradiation with light absorbed by the green porphyrin is required or employed with the composition. |
priorityDate |
1993-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |